COPD and the left heart

Clinical Management of Chronic Obstructive Pulmonary Disease

Volumn , Issue , 2002, Pages 533-547

  Lee Chiong, Teofilo L ^a   Matthay, Richard A ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038662235     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (77)

1. Niederman MS, Matthay RA. Cardiovascular function in secondary pulmonary hypertension. Heart & Lung 1986; 15:341–351.
2. Scharf SM. Pulmonary heart disease. In Baum GL, Crapo JD, Celli BR, Karlinsky JB eds. Textbook of Pulmonary Diseases, 6th ed. Philadelphia: Lippincott-Raven, 1998: 1311–1326.
3. Kline LE, Crawford MH, MacDonald WJ, Schelbert H, O’Rourke RA, Moser KM. Noninvasive assessment of left ventricular performance in patients with chronic obstructive pulmonary disease. Chest 1977; 72:558–564.
4. Kachel RG. Left ventricular function in chronic obstructive pulmonary disease. Chest 1978; 74:286–290.
5. Fluck DC, Chandrasekar RG, Gardner FV. Left ventricular hypertrophy in chronic bronchitis. Br Heart J 1966; 28:92–97.
6. Kohama A, Tanouchi J, Hori M, Kitabatake A, Kamada T. Pathologic involvement of the left ventricle in chronic cor pulmonale. Chest 1990; 98:794–800.
7. Baum GL, Schwartz A, Llamas R, Castillo C. Left ventricular function in chronic obstructive lung disease. N Engl J Med 1971; 285:361–365.
8. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part two. Am J Crit Care Med 1994; 150:1158–1168.
9. Jezek V, Schrijen F. Left ventricular function in chronic obstructive pulmonary disease with and without cardiac failure. Clin Sci Mol Med 1973; 45:267–279.
10. Kral B, Vokrouhlicky L, Pidrman V, Endrys J, Tilser P, Hamet A, Cihulova L, Elias J, Mihulova L, Rozanek P, Jandik J. Possibilities and limitations of non-invasive techniques for the study of left ventricular function in chronic pulmonary disease. Cor Vasa 1981; 23:104–110.
11. Slutsky R, Hooper W. Ackerman W, Ashburn W, Gerber K, Moser K, Karliner J. Evaluation of left ventricular function in chronic pulmonary disease by exercise gated equilibrium radionuclide angiography. Am Heart J 1981; 101:414–420.
12. Tutar E, Kaya A, Gulec S, Ertas F, Erol C, Ozdemir O, Oral D. Echocardiographic evaluation of left ventricular diastolic function in chronic cor pulmonale. Am J Cardiol 1999; 83:1414–1419.
13. Olvey SK, Reduto LA, Stevens PM, Deaton WJ, Miller RR. First-pass radionuclide assessment of right and left ventricular ejection fraction in chronic pulmonary disease: effect of oxygen upon exercise response. Chest 1980; 78:4–9.
14. Matthay RA, Berger HJ, Davies RA, Loke J, Mahler DA, Gottschalk A, Zaret BL. Right and left ventricular exercise performance in chronic obstructive pulmonary disease: radionuclide assessment. Ann Intern Med 1980; 93:234–239.
15. Matthay RA, Ellis JH Jr., Steele PP. Methoxamine-induced increase in afterload. Effect on left ventricular performance in chronic obstructive pulmonary disease. Am Rev Respir Dis 1978; 117:871–877.
16. Matthay RA, Ellis JH Jr., Steele PP. Effect of dextran loading on left ventricular performance in chronic obstructive pulmonary disease. Am Heart J 1976; 92:730–736.
17. Inoue K, Sera K, Fukuzaki H. Evaluation with equilibrium radionuclide angiography of left ventricular systolic and diastolic function in pulmonary hypertension secondary to chronic pulmonary diseases. Kobe J Med Sci 1989; 35:239–254.
18. MacNee W, Morgan AD, Wathen CG, Muir AL, Flenley DC. Right ventricular performance during exercise in chronic obstructive pulmonary disease. Respiration 1985; 48: 206–211.
19. Siebold H, Roth U, Lippert R, Kohler J, Wieshammer S, Henze E, Stauch M. Left heart function in chronic obstructive lung disease. Klin Wochenschr 1986; 64:433–441.
20. Smith RP, Johnson MK, Ashley J, Rudkin ST, White RJ. Effect of exercise induced hypoxaemia on myocardial repolarisation in severe chronic obstructive pulmonary disease. Thorax 1998; 53:572–576.
21. Slutsky RA, Ackerman W, Karliner JS, Ashburn WL, Moser KM. Right and left ventricular dysfunction in patients with chronic obstructive lung disease. Assessment by firstpass radionuclide angiography. Am J Med 1980; 68:197–205.
22. Rice DL, Kearney DJ, Awe RJ, Jenkins DE. Left ventricular function during respiratory failure. Crit Care Med 1977; 5:193–198.
23. Jardin F, Gueret P, Prost JF, Farcot JC, Ozier Y, Bourdarias JP. Two-dimensional echocardiographic assessment of left ventricular function in chronic obstructive pulmonary disease. Am Rev Respir Dis 1984; 129:135–142.
24. Unger K, Shaw D, Karliner JS, Crawford M, O’Rourke RA, Moser KM. Evaluation of left ventricular performance in acutely ill patients with chronic obstructive lung disease. Chest 1975; 68:135–142.
25. Richard C, Teboul JL, Archambaud F, Hebert JL, Michaut P, Auzepy P. Left ventricular function during weaning of patients with chronic obstructive pulmonary disease. Int Care Med 1994; 20:181–186.
26. Fishman AP. Chronic cor pulmonale. Am Rev Respir Dis 1976; 114:775–794.
27. Murphy ML, de Soyza N, Thenabadu PN. Quantitation of fibrosis of the heart in chronic obstructive pulmonary disease with and without cor pulmonale. Chest 1983; 84:535–538.
28. Murphy ML, Adamson J, Hutcheson F. Left ventricular hypertrophy in patients with chronic bronchitis and emphysema. Ann Intern Med 1974; 81:307–313.
29. Davies H, Overy HR. Left ventricular function in cor pulmonale. Chest 1970; 58:8–14.
30. Gupta S, Khastgir T, Gupta MP, Sethi KK, Manoharan S. Clinical, haemodynamic and echocardiographic study in chronic cor pulmonale. J Assoc Physicians India 1989; 37: 373–376.
31. Mal H, Levy A, Laperche T, Sleiman C, Stievenart JL, Cohen-Solal A, Brugiere O, Leseche G, Jebrak G, Fournier M. Limitations of radionuclide angiographic assessment of left ventricular systolic function before lung transplantation. Am J Respir Crit Care Med 1998; 158:1396–1402.
32. Jezek V. Left ventricular volumetry and function in chronic cor pulmonale. Cor Vasa 1981; 23:94–103.
33. Steele P, Ellis JH, Van Dyke D, Sutton F, Creagh E, Davies H. Left ventricular ejection fraction in severe chronic obstructive airways disease. Am J Med 1975; 59:21–28.
34. Kline LE. Crawford MH, MacDonald WJ, Shelbert H, O’Rourke RA, Moser KM. Noninvasive assessment of left ventricular performance in patients with chronic obstructive pulmonary disease. Chest 1977; 72:558–564.
35. Matthay RA, Berger HJ. Cardiovascular performance in chronic obstructive pulmonary diseases. Med Clin North Am 1981; 65:489–524.
36. Braunwald E. Pathophysiology of heart failure. In: Braunwald E, ed. Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia: Saunders, 1980:453–471.
37. Furey SA, Zieska HA, Levy MN. The essential function of the right ventricle. Am Heart J 1984; 107:404–410.
38. Laks MM, Garner D, Swan HJC. Volumes and compliances measured simultaneously in the right and left ventricles of the dog. Circ Res 1967; 20:565–569.
39. Matthay RA, Niederman MS, Wiedemann HP. Cardiovascular-pulmonary interaction in chronic obstructive pulmonary disease with special reference to the pathogenesis and management of cor pulmonale. Med Clin North Am 1990; 74:571–618.
40. Bove AA, Santamore WP. Ventricular interdependence. Progress in cardiovascular diseases 1981; 23:365–388.
41. Schena M, Clini E, Errera D, Quadri A. Echo-Doppler evaluation of left ventricular impairment in chronic cor pulmonale. Chest 1996; 109:1446–1451.
42. Louridas G, Patakas D, Stavropoulos C. Left ventricular function in patients with chronic obstructive pulmonary disease. Cardiology 1981; 67:73–80.
43. Endrys J, Kral B, Elias J, Hamet A. Left ventricular overload caused by collateral pulmonary circulation in chronic pneumopathies—myth or reality? Cor Vasa 1981; 23: 121–125.
44. Butler J, Schrijen F, Henriquez A, Polu JM, Albert RK. Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Am Rev Respir Dis 1988; 138:350–354.
45. Buda AJ, Pinsky MR, Ingels NB Jr., Daughters GT 2d, Stinson EB, Alderman EL. Effect of intrathoracic pressure on left ventricular performance. N Engl J Med 1979; 301:453–459.
46. Murphy ML, Adamson J, Hutcheson F. Left ventricular hypertrophy in patients with chronic bronchitis and emphysema. Ann Intern Med 1974; 81:307–313.
47. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part one. Am J Respir Crit Care Med 1994; 150:833–852.
48. Gabinski C. Left ventricular function in chronic obstructive pulmonary disease. Cor Vasa 1980; 22:238–244.
49. Bianco JA, Laskey WK, Makey DG, Shafer RB. Angiotensin infusion effects on left ventricular function. Chest 1980; 77:172–175.
50. Lockhart A, Tzareva M, Nader F, Leblanc P, Schrijen F, Sadoul P. Elevated pulmonary artery pressure at rest and during exercise in chronic bronchitis: fact or fancy. Clin Sci 1969; 37:503–517.
51. Williams JF Jr, Behnke RH. The effect of pulmonary emphysema upon cardiopulmonary hemodynamics at rest and during exercise. Ann Intern Med 1964; 60:824–842.
52. Olgiati R, Atchou G, Cerretelli P. Hemodynamic effects of resistive breathing. J Appl Physiol 1986; 60:846–853.
53. Sakamaki F, Satoh T, Nagaya N, Kyotani S, Nakanishi N, Ishida Y. Abnormality of left ventricular sympathetic nervous function assessed by (123)I-metaiodobenzylguanidine imaging in patients with COPD. Chest 1999; 116:1575–1581.
54. Matthay RA. Effects of theophylline on cardiovascular performance in chronic obstructive pulmonary disease. Chest 1985; 88:112S–117S.
55. Parker JO, Kelkar K, West RO. Hemodynamic effects of aminophylline in cor pulmonale. Circulation 1966; 37:17–25.
56. Parker JO, Ashekian PB, DiGiorgi S, West RO. Hemodynamic effects of aminophylline in chronic obstructive pulmonary disease. Circulation 1967; 35:365–372.
57. Matthay RA, Berger HJ, Loke J, Gottschalk A, Zaret BL. Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease: noninvasive assessment of radionuclide angiocardiography. Am J Med 1978; 65:903–910.
58. Matthay RA, Berger HJ, Davies R, Loke J, Gottschalk A, Zaret BL. Improvement in cardiac performance in oral long acting theophylline in chronic obstructive pulmonary disease. Am Heart J 1982; 104:1022–1026.
59. Self TH, Chafin CC, Soberman JE. Effect of disease states on theophylline serum concentrations: are we still vigilant? Am J Med Sci 2000; 319:177–182.
60. Piafsky KM, Sitar DS, Rango RE, Ogilvie R. Theophylline kinetics in acute pulmonary edema. Clin Pharmacol Ther 1977; 21:310–316.
61. Kuntz HD, Straub H, May B. Theophylline elimination in congestive heart failure. Klin Wochenschr 1983; 61:1105–1106.
62. Vicuna N, McNay JL, Ludden TM, Schwertner H. Impaired theophylline clearance in patients with cor pulmonale. Br J Clin Pharmacol 1979; 7:33–37.
63. Johnston DL, Scanlon PD, Hodge DO, Glynn RB, Hung JC, Gibbons RJ. Pulmonary function monitoring during adenosine myocardial perfusion scintigraphy in patients with chronic obstructive pulmonary disease. Mayo Clin Proc 1999; 74:339–346.
64. Giagounidis AA, Schafer S, Klein RM, Aul C, Strauer BE. Adenosine is worth trying in patients with paroxysmal supraventricular tachycardia on chronic theophylline medication. Eur J Med Res 1998; 3:380–382.
65. Wunderlich J, Macha HN, Wudicke H, Huckauf H. Beta-adrenoceptor blockers and terbutaline in patients with chronic obstructive lung disease. Effects and interaction after oral administration. Chest 1980; 78:714–720.
66. Chester EH, Schwartz HJ, Fleming GM. Adverse effect of propranolol on airway function in nonasthmatic chronic obstructive lung disease. Chest 1981; 79:540–544.
67. Nordstrom LA, MacDonald F, Gobel FL. Effect of propranolol on respiratory function and exercise tolerance in patients with chronic obstructive lung disease. Chest 1975; 67:287–292.
68. Fenster PE, Hasan FM, Abraham T, Woolfenden J. Effect of metoprolol on cardiac and pulmonary function in chronic obstructive pulmonary disease. Clin Cardiol 1983; 6: 125–129.
69. Clague HW, Ahmad D, Carruthers SG. Influence of cardioselectivity and respiratory disease on pulmonary responsiveness to beta-blockade. Eur J Clin Pharmacol 1984; 27: 517–523.
70. Gold MR, Dec GW, Cocca-Spofford D, Thompson BT. Esmolol and ventilatory function in cardiac patients with COPD. Chest 1991; 100:1215–1218.
71. Weber MA. Hypertension with concomitant conditions: the changing role of beta-adrenoceptor blockade. Am Heart J 1991; 121:716–723.
72. Dorow P, Bethge H, Tonnesmann U. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. Eur J Clin Pharmacol 1986; 31:143–147.
73. Dorow P, Schiess W. Bopindol, pindolol, and atenolol in patients with chronic obstructive lung disease. Klin Wochenschr 1986; 64:366–369.
74. Areskog NH, Cullhead I, Ringqvist I, Strom G. Cardiovascular and respiratory effects of the beta-adrenoceptive antagonist sotalol: studies in health, angina pectoris and obstructive lung disease. Eur J Clin Pharmacol 1975; 8:403–408.
75. Singh SN, Fisher SG, Deedwania PC, Rohatgi P, Singh BN, Fletcher RD. Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure- Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320). Journal of the American College of Cardiology 1997; 30: 514–517.
76. Thurnheer R, Laube I, Kaufmann PA, Stumpe KD, Stammberger U, Bloch KE, Weder W, Russi EW. Practicability and safety of dipyridamole cardiac imaging in patients with severe chronic obstructive pulmonary disease. Eur J Nucl Med 1999; 26:812–817.
77. Milne N, Light RW, Chetty KG. Exercise-induced changes in left ventricular function after phlebotomy in patients with polycythemic COPD. J Thorac Imaging 1990; 5:68–72.